Celestica, Inc. (CLS) Analyst Forecast

$347.63

$8.17 (2.41%)
Last update: 09:00 AM EST
Day's range
$335.14
Day's range
$365.52

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
08/07/2026 Barclays Tim Long $406.00 $314.53   29.08%
07/29/2026 RBC Capital Paul Treiber $450.00 $328.43   37.02%
07/29/2026 UBS David Vogt $410.00 $334.83   22.45%
07/29/2026 Wolfe Research George Notter $475.00 $350.20   35.64%
04/29/2026 RBC Capital Paul Treiber $440.00 $360.16   22.17%
04/29/2026 Barclays Tim Long $441.00 $361.71   21.92%
04/28/2026 Stifel Nicolaus Ruben Roy $445.00 $361.71   23.03%
03/11/2026 CIBC Todd Coupland $360.00 $267.23   34.72%
10/29/2025 Goldman Sachs Michael Ng $440.00 $326.45   34.78%
10/29/2025 Barclays Tim Long $357.00 $326.45   9.36%
10/22/2025 RBC Capital Paul Treiber $315.00 $264.69   19.01%
02/03/2025 Stifel Nicolaus Ruben Roy $140.00 $120.88   15.82%
01/31/2025 RBC Capital Paul Treiber $140.00 $123.47   13.39%
10/24/2024 BMO Capital Thanos Moschopoulos $72.00 $66.51   8.26%
10/24/2024 RBC Capital Maxim Matushansky $75.00 $57.47   30.5%
07/26/2024 Argus Research Kristina Ruggeri $58.00 $52.67   10.12%
07/26/2024 Stifel Nicolaus Matthew Sheerin $58.00 $51.07   13.57%
07/26/2024 Canaccord Genuity Robert Young $70.00 $51.07   37.07%
05/15/2024 US Capital Advisors Steven Fox $60.00 $48.00   25%
05/13/2024 Stifel Nicolaus Matthew Sheerin $51.00 $46.99   8.53%

Celestica, Inc. FAQ's

Celestica, Inc. has been rated by research analysts at Barclays, RBC Capital, CIBC, UBS, Wolfe Research, Stifel Nicolaus in the past 90 days.